SCHEMBL30976376

SCHEMBL30976376

COc1ccc(C2(C)CCN(Cc3ccccc3)CC2)cc1

nearest known ligand 0.68

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ SIGMAR1 Q99720 8/20 0.68
▸ CYP2D6 P10635 1/20 0.60
▸ TSHR P16473 1/20 0.60
▸ LMNA P02545 1/20 0.53
▸ MEN1 O00255 2/20 0.52
▸ KMT2A Q03164 2/20 0.52
▸ MMP1 P03956 1/20 0.52
▸ MMP9 P14780 1/20 0.52
▸ MMP13 P45452 1/20 0.52
▸ ADAM17 P78536 1/20 0.52
▸ POLB P06746 1/20 0.52
▸ CHRM3 P20309 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3252230 0.86 OPRL1 (0.65) SIGMAR1CYP2D6TSHRLMNAMEN1
Hydrochloric Acid SCHEMBL6160179 0.85 POLB (0.66) SIGMAR1CYP2D6TSHRLMNAMEN1
SCHEMBL27550808 0.85 OPRL1 (0.63) SIGMAR1CYP2D6TSHRLMNAMEN1
SCHEMBL240629 0.84 OPRL1 (0.73) SIGMAR1CYP2D6TSHRLMNAMEN1
SCHEMBL654066 0.84 CCR3 (0.68) SIGMAR1POLB
SCHEMBL1513592 0.82 OPRL1 (0.53) SIGMAR1CYP2D6TSHRLMNAMEN1
SCHEMBL15178456 0.82 OPRL1 (0.53) SIGMAR1CYP2D6TSHRLMNAMEN1
SCHEMBL28217942 0.81 SIGMAR1 (1.00) SIGMAR1LMNAMEN1KMT2APOLB
SCHEMBL7016275 0.80 SIGMAR1 (0.72) SIGMAR1CYP2D6TSHRMEN1KMT2A
SCHEMBL4272060 0.78 SIGMAR1 (0.60) SIGMAR1CYP2D6TSHRCHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4619387-A1 PHTHALAZINONE BASED MODULATORS FOR THE TREATMENT OF DISEASE Soley Therapeutics, Inc. (US) 2025-09-24 — — EP disclosed
WO-2024108131-A1 PHTHALAZINONE BASED MODULATORS FOR THE TREATMENT OF DISEASE SOLEY THERAPEUTICS, INC. (US) 2024-05-23 — — WO disclosed
Send feedback